Stay updated on Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s revision label in the Record History updates from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry was added to the study record history, updating the version from v3.6.3 to v3.6.4. This change appears to be an administrative update to the page rather than a modification to the trial data or content.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry 'Revision: v3.6.3' was added to the Record History, replacing the previous 'Revision: v3.6.2'. This reflects a newer system release for the page history.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry labeled v3.6.2 was added to the history and the previous revision v3.6.0 was removed from the visible history, updating the record of the study's release notes.SummaryDifference0.1%

- Check74 days agoChange DetectedUpdates to the study record history page include a new Revision: v3.6.0 and removal of the previous v3.5.5 label. In addition, the page now presents a 'Check who can join' option and a 'Find Contact Information' link to assist potential participants in assessing eligibility and contacting the study team.SummaryDifference0.5%

- Check81 days agoChange DetectedThe study history now marks SPARTAN as Recruiting and updates the page to reflect current enrollment. It also adds key sections such as Contacts/Locations, Eligibility, Study Design, Study Description, Study Status, Study Identification, and Recruitment Status, replacing the older 'Active, not recruiting' label and the previous trial title wording.SummaryDifference1%

Stay in the know with updates to Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page.